查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1883043

连续性肾臟替代疗法 (CRRT) 耗材市场规模、占有率、成长及全球产业分析：按类型、应用和地区划分的洞察与预测 (2024-2032)

Continuous Renal Replacement Therapy (CRRT) Consumables Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 130 Pages | 商品交期: 请询问到货日

价格

连续性肾臟替代疗法 (CRRT) 耗材市场成长驱动因子

在全球急性肾损伤 (AKI) 和慢性肾臟病负担日益加重的背景下，全球连续性肾臟替代疗法 (CRRT) 耗材市场持续成长。根据最新的行业分析，受重症监护室 (ICU) 入院人数增加和对连续性肾臟替代疗法依赖性提高的推动，预计到 2024 年，市场规模将达到 8.47 亿美元。到 2025 年，受 CRRT 技术进步和全球重症监护室对 CRRT 的日益普及的推动，预计市场规模将进一步扩大至 9.126 亿美元。预计到 2032 年，CRRT 耗材市场规模将达到 15.815 亿美元，这反映了数位化工具的日益普及、产品创新以及基于价值的肾臟护理模式的发展。

市场驱动因素

最强劲的成长因素之一是急性肾损伤 (AKI) 发生率的上升，尤其是在重症患者中。根据 2023 年 9 月《肾臟病学杂誌》的报道，全球每年将有 1,330 万人发生 AKI，其中大多数发生在低收入和中等收入地区。 AKI 患者数量的增加直接推高了重症监护室 (ICU) 对 CRRT 治疗的需求，导致滤器、透析液、置换液和抗凝血剂的消耗量增加。

产品创新也进一步推动了市场成长。 2023年3月，Quanta Dialysis Technologies的Quanta Dialysis System获得FDA批准，该系统具备CVVHD和SCUF模式，提高了重症监护环境下治疗的可及性和灵活性。

市场限制因子

儘管CRRT具有诸多益处，但由于需要专门的基础设施、熟练的ICU医护人员以及高昂的治疗费用，其普及受到限制。 2025年《肾臟国际报告》的一项调查指出，由于缺乏专业知识和高昂的费用，CRRT服务在印度大部分地区仍然无法取得。报告指出，在印度，单次CRRT治疗的费用在500至800美元之间，这使得许多发展中国家的患者难以负担这项治疗。此外，与过滤器、管路、透析液和耗材相关的持续费用也进一步加重了治疗负担，限制了其广泛应用。

市场机会

随着医院向以价值为导向、以结果为驱动的肾臟护理模式转型，对先进的CRRT耗材的需求持续增长。製造商正致力于开发新一代过滤器、输液装置和滤芯，以提高毒素清除效率并减少治疗中断。 2024年3月，费森尤斯医疗宣布推出一款基于扩增实境（AR）的培训应用程序，旨在简化重症监护室（ICU）专业人员的CRRT培训，这标誌着肾臟护理正朝着数位化整合的方向发展。

市场挑战

一个显着的挑战是缺乏标准化的治疗方案，因为CRRT的设定在不同国家、医院和医生之间差异很大。剂量、治疗选择、抗凝血方法和液体平衡策略的差异使得企业难以设计出通用的CRRT耗材。这种缺乏标准化的情况增加了监管审批的难度，并减缓了创新耗材的普及。

主要市场趋势

技术创新正在重塑 CRRT 领域。数位追踪、自动化治疗控制和整合感测器正成为现代 CRRT 系统的关键组成部分。百特公司近期推出的 PrisMax 系统将 TherMax 血液加热技术与先进的治疗设定相结合，简化了 CRRT 管理。医院与製造商之间的订阅协议也正在兴起，这降低了营运成本并确保了耗材的稳定供应。

区域展望

北美

北美将在 2024 年继续保持最大市场地位，达到 3.236 亿美元。这反映了 CRRT 的高普及率、先进的透析基础设施和强大的 ICU 容量。由于急性肾损伤 (AKI) 的日益普遍以及政府支持的各项举措（例如美国肾臟护理 2025 年肾臟病学培训计划），美国将继续引领市场，加强肾臟护理团队建设。

欧洲

在强大的临床研究、先进的医院基础设施以及日益严重的肾臟疾病负担的支持下，欧洲在2024年占据了较大的市场占有率。德国在肾臟疾病预防研究方面投资了1208万美元，进一步推动了该地区的成长。

亚太地区

预计到2032年，亚太地区的复合年增长率将最高。人口老化和肾臟疾病发病率的上升（例如，到2023年，中国60岁及以上的老年人口将达到2.97亿）显着增加了对连续性肾臟替代疗法（CRRT）的需求。医院网路的扩张和医疗保健投资的增加进一步增强了市场前景。

拉丁美洲、中东和非洲

由于肾臟护理计画的扩展，预计拉丁美洲将保持稳定成长。同时，中东和非洲对透析中心和重症监护室 (ICU) 升级的投资正在推动市场发展。例如，SAHA 和 PureHealth 正在合作建立阿布达比透析中心，计划于 2025 年投入使用。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要国家末期肾病患病率
  • 主要公司新产品发布
  • 主要产业趋势（併购、合作等）
  • 肾臟替代疗法的技术进步治疗

第五章：全球连续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测 (2019-2032)

  • 按类型划分的市场分析、洞察与预测
    • 透析液
    • 置换液
    • 滤镜
    • 导管
    • 其他
  • 按模式划分的市场分析、洞察与预测
    • 慢速连续超滤 (SCUF)
    • 连续性静脉-静脉血液滤过 (CVVH)
    • 连续性静脉-静脉血液透析 (CVVHD)
    • 连续性静脉-静脉血液透析滤过 (CVVHDF)
  • 按地区划分的市场分析、洞察与预测
    • 北美美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章：北美连续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测 (2019-2032)

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 欧洲其他地区

第七章：亚太地区连续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测 (2019-2032)

  • 依国家/地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第八章：拉丁美洲连续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测 (2019-2032)

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第九章：中东和非洲连续性肾臟替代疗法 (CRRT) 耗材市场分析、洞察与预测 (2019-2032)

  • 依国家划分
    • 海湾合作委员会 (GCC)
    • 南非
    • 中东其他地区非洲

第十章：竞争分析

  • 全球市占率分析（2024）
  • 公司简介
  • 百特
  • 贝朗集团
  • 费森尤斯医疗股公司
  • 旭化成医疗株式会社（旭化成株式会社）
  • 尼普洛
  • 东丽医疗株式会社（东丽工业株式会社）
  • 日机装株式会社
  • 美敦力
  • 其他主要参与者
Product Code: FBI113670

Growth Factors of continuous renal replacement therapy (CRRT) consumables Market

The global continuous renal replacement therapy (CRRT) consumables market continues to rise as the burden of acute kidney injury (AKI) and chronic kidney disease accelerates worldwide. According to the latest industry analysis, the market was valued at USD 847.0 million in 2024, supported by growing ICU admissions and increasing reliance on continuous renal therapies. In 2025, the market is projected to increase further to USD 912.6 million, driven by advancements in CRRT technologies and broader adoption across intensive care units globally. By 2032, the CRRT consumables market is forecasted to reach USD 1,581.5 million, reflecting the growing integration of digital tools, product innovation, and value-based renal care models.

Market Drivers

One of the strongest growth drivers is the rising incidence of acute kidney injury, especially among critically ill patients. The Journal of Nephrology reported in September 2023 that 13.3 million individuals worldwide develop AKI every year, with most cases occurring in low- and middle-income regions. The growing AKI population directly increases the demand for CRRT therapies in ICU settings, leading to higher consumption of filters, dialysates, replacement solutions, and anticoagulants.

Product innovation further fuels market growth. In March 2023, Quanta Dialysis Technologies received FDA approval for its Quanta Dialysis System featuring CVVHD and SCUF modes, improving accessibility and treatment flexibility for critical care environments.

Market Restraints

Despite its benefits, CRRT adoption is restricted by the need for specialized infrastructure, skilled ICU staff, and high treatment costs. A 2025 Kidney International Reports study highlighted that CRRT services remain unavailable in most parts of India due to limited expertise and high costs. The same report noted that each CRRT session in India costs USD 500-800, making the therapy inaccessible for many patients in developing regions. The recurring expenses associated with filters, tubing sets, dialysates, and consumables further add to the financial burden, limiting widespread use.

Market Opportunities

As hospitals shift toward value-based, outcome-oriented renal care, demand for advanced CRRT consumables continues to expand. Manufacturers are increasingly focusing on creating next-generation filters, fluid sets, and cartridges designed to improve toxin removal efficiency and reduce therapy interruptions. In March 2024, Fresenius Medical Care launched an augmented-reality-based training app to simplify CRRT education for ICU professionals, representing a move toward digitally integrated renal care.

Market Challenges

A notable challenge is the lack of standardized treatment protocols, as CRRT settings differ significantly by country, hospital, and physician. Variations in dosing, modality choice, anticoagulation methods, and fluid balance strategies make it difficult for companies to design universally compatible CRRT consumables. This lack of standardization also complicates regulatory approvals and slows adoption of innovative consumable products.

Key Market Trends

Technological innovation is reshaping the CRRT landscape. Digital tracking features, automated therapy controls, and integrated sensors are becoming vital components of modern CRRT systems. Baxter's PrisMax system, launched earlier, integrates TherMax blood warming technology and advanced therapy settings to simplify CRRT management. Subscription-based agreements between hospitals and manufacturers are also emerging, reducing operational costs and ensuring steady supply of consumables.

Regional Outlook

North America

North America remained the largest market in 2024, valued at USD 323.6 million, reflecting high CRRT adoption, advanced dialysis infrastructure, and strong ICU capacity. The U.S. continues to lead due to increased AKI prevalence and government support initiatives such as U.S. Renal Care's 2025 nephrology training program to strengthen the renal workforce.

Europe

Europe held a significant share in 2024, supported by strong clinical research, advanced hospital infrastructure, and rising renal disease burden. Germany's USD 12.08 million investment in kidney disease prevention research further enhances regional growth.

Asia Pacific

Asia Pacific is expected to record the highest CAGR through 2032. Aging populations and rising kidney disease incidence-such as China's 297 million population aged 60+ in 2023-significantly increase CRRT demand. Expanding hospital networks and increasing healthcare investment further strengthen market prospects.

Latin America & Middle East/Africa

Latin America shows steady growth due to expanding renal care programs, while the Middle East & Africa benefit from investments in dialysis centers and ICU upgrades, such as the 2025 partnership between SAHA and PureHealth to establish a dialysis center in Abu Dhabi.

Conclusion

With market size increasing from USD 847.0 million in 2024 to USD 1,581.5 million by 2032, the CRRT consumables market is on a strong growth trajectory. Rising AKI prevalence, growing ICU capacity, product innovation, and digital integration will continue to shape market expansion. Key players such as Baxter, Fresenius Medical Care, Medtronic, and Asahi Kasei are expected to drive future advancements through strategic partnerships and technology-driven product development.

Segmentation

By Type

  • Dialysates
  • Replacement Solutions
  • Filters
  • Catheters
  • Others

By Modality

  • Slow Continuous Ultra Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

By Geography

  • North America (By Type, Modality, and Country)
    • U.S.
    • Canada
  • Europe (By Type, Modality, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (By Type, Modality, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America (By Type, Modality, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Type, Modality, and Country/Sub-region)
    • GCC
    • South Africa
    • Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of End Stage Renal Disease, Key Countries
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
  • 4.4. Technological Advancements in Renal Replacement Therapy

5. Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Type
    • 5.1.1. Dialysates
    • 5.1.2. Replacement Solutions
    • 5.1.3. Filters
    • 5.1.4. Catheters
    • 5.1.5. Others
  • 5.2. Market Analysis, Insights and Forecast - By Modality
    • 5.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 5.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 5.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 5.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 5.3. Market Analysis, Insights and Forecast - By Region
    • 5.3.1. North America
    • 5.3.2. Europe
    • 5.3.3. Asia Pacific
    • 5.3.4. Latin America
    • 5.3.5. Middle East & Africa

6. North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Type
    • 6.1.1. Dialysates
    • 6.1.2. Replacement Solutions
    • 6.1.3. Filters
    • 6.1.4. Catheters
    • 6.1.5. Others
  • 6.2. Market Analysis, Insights and Forecast - By Modality
    • 6.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 6.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 6.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 6.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 6.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 6.3.1. U.K.
    • 6.3.2. Germany
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Scandinavia
    • 6.3.7. Rest of Europe

7. Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Type
    • 7.1.1. Dialysates
    • 7.1.2. Replacement Solutions
    • 7.1.3. Filters
    • 7.1.4. Catheters
    • 7.1.5. Others
  • 7.2. Market Analysis, Insights and Forecast - By Modality
    • 7.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 7.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 7.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 7.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.3.1. Japan
    • 7.3.2. China
    • 7.3.3. India
    • 7.3.4. Australia
    • 7.3.5. Southeast Asia
    • 7.3.6. Rest of Asia Pacific

8. Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Type
    • 8.1.1. Dialysates
    • 8.1.2. Replacement Solutions
    • 8.1.3. Filters
    • 8.1.4. Catheters
    • 8.1.5. Others
  • 8.2. Market Analysis, Insights and Forecast - By Modality
    • 8.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 8.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 8.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 8.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.3.1. Brazil
    • 8.3.2. Mexico
    • 8.3.3. Rest of Latin America

9. Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Type
    • 9.1.1. Dialysates
    • 9.1.2. Replacement Solutions
    • 9.1.3. Filters
    • 9.1.4. Catheters
    • 9.1.5. Others
  • 9.2. Market Analysis, Insights and Forecast - By Modality
    • 9.2.1. Slow Continuous Ultra Filtration (SCUF)
    • 9.2.2. Continuous Venovenous Hemofiltration (CVVH)
    • 9.2.3. Continuous Venovenous Hemodialysis (CVVHD)
    • 9.2.4. Continuous Venovenous Hemodiafiltration (CVVHDF)
  • 9.3. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.3.1. GCC
    • 9.3.2. South Africa
    • 9.3.3. Rest of Middle East & Africa

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2024)
  • 10.2. Company Profiles
    • 10.2.1. Baxter
      • 10.2.1.1. Overview
      • 10.2.1.2. Products
      • 10.2.1.3. SWOT Analysis
      • 10.2.1.4. Recent Developments
      • 10.2.1.5. Strategies
      • 10.2.1.6. Financials (Based on Availability)
    • 10.2.2. B Braun SE
      • 10.2.2.1. Overview
      • 10.2.2.2. Products
      • 10.2.2.3. SWOT Analysis
      • 10.2.2.4. Recent Developments
      • 10.2.2.5. Strategies
      • 10.2.2.6. Financials (Based on Availability)
    • 10.2.3. Fresenius Medical Care AG & Co. KGaA
      • 10.2.3.1. Overview
      • 10.2.3.2. Products
      • 10.2.3.3. SWOT Analysis
      • 10.2.3.4. Recent Developments
      • 10.2.3.5. Strategies
      • 10.2.3.6. Financials (Based on Availability)
    • 10.2.4. Asahi Kasei Medical Co., Ltd. (Asahi Kasei Corporation)
      • 10.2.4.1. Overview
      • 10.2.4.2. Products
      • 10.2.4.3. SWOT Analysis
      • 10.2.4.4. Recent Developments
      • 10.2.4.5. Strategies
      • 10.2.4.6. Financials (Based on Availability)
    • 10.2.5. NIPRO
      • 10.2.5.1. Overview
      • 10.2.5.2. Products
      • 10.2.5.3. SWOT Analysis
      • 10.2.5.4. Recent Developments
      • 10.2.5.5. Strategies
      • 10.2.5.6. Financials (Based on Availability)
    • 10.2.6. TORAY MEDICAL CO, LTD. (TORAY INDUSTRIES, INC.)
      • 10.2.6.1. Overview
      • 10.2.6.2. Products
      • 10.2.6.3. SWOT Analysis
      • 10.2.6.4. Recent Developments
      • 10.2.6.5. Strategies
      • 10.2.6.6. Financials (Based on Availability)
    • 10.2.7. Nikkiso Co., Ltd.
      • 10.2.7.1. Overview
      • 10.2.7.2. Products
      • 10.2.7.3. SWOT Analysis
      • 10.2.7.4. Recent Developments
      • 10.2.7.5. Strategies
      • 10.2.7.6. Financials (Based on Availability)
    • 10.2.8. Medtronic
      • 10.2.8.1. Overview
      • 10.2.8.2. Products
      • 10.2.8.3. SWOT Analysis
      • 10.2.8.4. Recent Developments
      • 10.2.8.5. Strategies
      • 10.2.8.6. Financials (Based on Availability)
    • 10.2.9. Other Prominent Players

List of Tables

  • Table 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 4: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 7: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 8: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 9: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 10: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 11: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 12: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 13: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 14: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 15: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Type, 2019-2032
  • Table 17: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, by Modality, 2019-2032
  • Table 18: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024 & 2032
  • Figure 3: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024 & 2032
  • Figure 4: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Region, 2024 & 2032
  • Figure 5: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 6: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 7: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 8: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 9: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country, 2024 & 2032
  • Figure 10: North America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country, 2024
  • Figure 11: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 12: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 13: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 14: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 15: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 16: Europe Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 17: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 18: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 19: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 20: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 21: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 22: Asia Pacific Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 23: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 24: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 25: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 26: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 27: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 28: Latin America Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 29: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Type, 2024 & 2032
  • Figure 30: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Type, 2024
  • Figure 31: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), by Modality, 2024 & 2032
  • Figure 32: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), by Modality, 2024
  • Figure 33: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 34: Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Consumables Market Value Share (%), By Country/ Sub-region, 2024
  • Figure 35: Global Continuous Renal Replacement Therapy (CRRT) Consumables Market Share (%), By Company, 2024